{reportSlug=global-ibs-treatment-market, reportId=73428, mktKeyword=IBS Treatment, cagr=0.00, publishDate=Mar 2024, priceOption2=6500, reportTitle=IBS Treatment Comprehensive Study by Type (IBS-D, IBS-C, IBS-M), Application (Hospitals, Clinics, Research Laboratories), Drug (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=173, priceOption1=3450, forecastYr=2030, noOfPages=227, reportKey=73073, breadcrum=Global (United States, European Union and China) IBS Treatment}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2024
227 Pages
86 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries